Advertisement

Index by author

June 01, 1995; Volume 23,Issue 6

B

  1. Bhagwat, S V

    1. Rat brain cytochrome P450. Reassessment of monooxygenase activities and cytochrome P450 levels.
      S V Bhagwat, M R Boyd and V Ravindranath
      Drug Metabolism and Disposition June 1995, 23 (6) 651-654;

  2. Bijloo, G J

    1. Computer prediction and experimental validation of cytochrome P4502D6-dependent oxidation of GBR 12909.
      M J de Groot, G J Bijloo, K T Hansen and N P Vermeulen
      Drug Metabolism and Disposition June 1995, 23 (6) 667-669;

  3. Boudinot, F D

    1. Lymphatic distribution of 3'-azido-3'-deoxythymidine and 3'-azido-2',3'-dideoxyuridine in mice.
      K K Manouilov, C A White, F D Boudinot, I I Fedorov and C K Chu
      Drug Metabolism and Disposition June 1995, 23 (6) 655-658;

  4. Boyd, M R

    1. Rat brain cytochrome P450. Reassessment of monooxygenase activities and cytochrome P450 levels.
      S V Bhagwat, M R Boyd and V Ravindranath
      Drug Metabolism and Disposition June 1995, 23 (6) 651-654;

  5. Burmaster, S D

    1. Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes.
      K H Ling, G A Leeson, S D Burmaster, R H Hook, M K Reith and L K Cheng
      Drug Metabolism and Disposition June 1995, 23 (6) 631-636;

C

  1. Cheng, L K

    1. Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes.
      K H Ling, G A Leeson, S D Burmaster, R H Hook, M K Reith and L K Cheng
      Drug Metabolism and Disposition June 1995, 23 (6) 631-636;

  2. Chiba, M

    1. Glutathione depletion kinetics with acetaminophen. A simulation study.
      M Chiba and K S Pang
      Drug Metabolism and Disposition June 1995, 23 (6) 622-630;

  3. Cho, A K

    1. Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers.
      L Y Lin, Y Kumagai, A Hiratsuka, S Narimatsu, T Suzuki, Y Funae, E W Distefano and A K Cho
      Drug Metabolism and Disposition June 1995, 23 (6) 610-614;

  4. Chu, C K

    1. Lymphatic distribution of 3'-azido-3'-deoxythymidine and 3'-azido-2',3'-dideoxyuridine in mice.
      K K Manouilov, C A White, F D Boudinot, I I Fedorov and C K Chu
      Drug Metabolism and Disposition June 1995, 23 (6) 655-658;

D

  1. de Groot, M J

    1. Computer prediction and experimental validation of cytochrome P4502D6-dependent oxidation of GBR 12909.
      M J de Groot, G J Bijloo, K T Hansen and N P Vermeulen
      Drug Metabolism and Disposition June 1995, 23 (6) 667-669;

  2. Distefano, E W

    1. Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers.
      L Y Lin, Y Kumagai, A Hiratsuka, S Narimatsu, T Suzuki, Y Funae, E W Distefano and A K Cho
      Drug Metabolism and Disposition June 1995, 23 (6) 610-614;

F

  1. Fagliano, J A

    1. Urine chromium screening.
      J A Fagliano, M Gochfeld, J E Savrin and A H Stern
      Drug Metabolism and Disposition June 1995, 23 (6) 607-609;

  2. Fedorov, I I

    1. Lymphatic distribution of 3'-azido-3'-deoxythymidine and 3'-azido-2',3'-dideoxyuridine in mice.
      K K Manouilov, C A White, F D Boudinot, I I Fedorov and C K Chu
      Drug Metabolism and Disposition June 1995, 23 (6) 655-658;

  3. Funae, Y

    1. Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers.
      L Y Lin, Y Kumagai, A Hiratsuka, S Narimatsu, T Suzuki, Y Funae, E W Distefano and A K Cho
      Drug Metabolism and Disposition June 1995, 23 (6) 610-614;

G

  1. Gochfeld, M

    1. Urine chromium screening.
      J A Fagliano, M Gochfeld, J E Savrin and A H Stern
      Drug Metabolism and Disposition June 1995, 23 (6) 607-609;

H

  1. Hansen, K T

    1. Computer prediction and experimental validation of cytochrome P4502D6-dependent oxidation of GBR 12909.
      M J de Groot, G J Bijloo, K T Hansen and N P Vermeulen
      Drug Metabolism and Disposition June 1995, 23 (6) 667-669;

  2. He, M

    1. Inhibition of (S)-warfarin metabolism by sulfinpyrazone and its metabolites.
      M He, K L Kunze and W F Trager
      Drug Metabolism and Disposition June 1995, 23 (6) 659-663;

  3. Hiratsuka, A

    1. Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers.
      L Y Lin, Y Kumagai, A Hiratsuka, S Narimatsu, T Suzuki, Y Funae, E W Distefano and A K Cho
      Drug Metabolism and Disposition June 1995, 23 (6) 610-614;

  4. Hook, R H

    1. Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes.
      K H Ling, G A Leeson, S D Burmaster, R H Hook, M K Reith and L K Cheng
      Drug Metabolism and Disposition June 1995, 23 (6) 631-636;

K

  1. Kumagai, Y

    1. Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers.
      L Y Lin, Y Kumagai, A Hiratsuka, S Narimatsu, T Suzuki, Y Funae, E W Distefano and A K Cho
      Drug Metabolism and Disposition June 1995, 23 (6) 610-614;

  2. Kunze, K L

    1. Inhibition of (S)-warfarin metabolism by sulfinpyrazone and its metabolites.
      M He, K L Kunze and W F Trager
      Drug Metabolism and Disposition June 1995, 23 (6) 659-663;

L

  1. Leeson, G A

    1. Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes.
      K H Ling, G A Leeson, S D Burmaster, R H Hook, M K Reith and L K Cheng
      Drug Metabolism and Disposition June 1995, 23 (6) 631-636;

  2. Lin, L Y

    1. Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers.
      L Y Lin, Y Kumagai, A Hiratsuka, S Narimatsu, T Suzuki, Y Funae, E W Distefano and A K Cho
      Drug Metabolism and Disposition June 1995, 23 (6) 610-614;

  3. Ling, K H

    1. Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes.
      K H Ling, G A Leeson, S D Burmaster, R H Hook, M K Reith and L K Cheng
      Drug Metabolism and Disposition June 1995, 23 (6) 631-636;

M

  1. Mangold, J B

    1. Metabolism of cyclosporin G in the mouse, rat, and dog.
      J B Mangold, L C Rodriguez and Y K Wang
      Drug Metabolism and Disposition June 1995, 23 (6) 615-621;

  2. Manouilov, K K

    1. Lymphatic distribution of 3'-azido-3'-deoxythymidine and 3'-azido-2',3'-dideoxyuridine in mice.
      K K Manouilov, C A White, F D Boudinot, I I Fedorov and C K Chu
      Drug Metabolism and Disposition June 1995, 23 (6) 655-658;

  3. Mehvar, R

    1. Input rate-dependent stereoselective pharmacokinetics. Experimental evidence in verapamil-infused isolated rat livers.
      R Mehvar and J Reynolds
      Drug Metabolism and Disposition June 1995, 23 (6) 637-641;

N

  1. Narimatsu, S

    1. Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers.
      L Y Lin, Y Kumagai, A Hiratsuka, S Narimatsu, T Suzuki, Y Funae, E W Distefano and A K Cho
      Drug Metabolism and Disposition June 1995, 23 (6) 610-614;

P

  1. Pang, K S

    1. Glutathione depletion kinetics with acetaminophen. A simulation study.
      M Chiba and K S Pang
      Drug Metabolism and Disposition June 1995, 23 (6) 622-630;

  2. Phillips, D L

    1. Increased blood and brain cocaine concentrations with ethanol cotreatment in mice.
      S M Roberts, D L Phillips and I R Tebbett
      Drug Metabolism and Disposition June 1995, 23 (6) 664-666;

  3. Pinaire, J A

    1. Regulation of the Ah gene battery via Ah receptor-dependent and independent processes in cultured adult rat hepatocytes.
      G H Xiao, J A Pinaire, A D Rodrigues and R A Prough
      Drug Metabolism and Disposition June 1995, 23 (6) 642-650;

  4. Prough, R A

    1. Regulation of the Ah gene battery via Ah receptor-dependent and independent processes in cultured adult rat hepatocytes.
      G H Xiao, J A Pinaire, A D Rodrigues and R A Prough
      Drug Metabolism and Disposition June 1995, 23 (6) 642-650;

R

  1. Ravindranath, V

    1. Rat brain cytochrome P450. Reassessment of monooxygenase activities and cytochrome P450 levels.
      S V Bhagwat, M R Boyd and V Ravindranath
      Drug Metabolism and Disposition June 1995, 23 (6) 651-654;

  2. Reith, M K

    1. Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes.
      K H Ling, G A Leeson, S D Burmaster, R H Hook, M K Reith and L K Cheng
      Drug Metabolism and Disposition June 1995, 23 (6) 631-636;

  3. Reynolds, J

    1. Input rate-dependent stereoselective pharmacokinetics. Experimental evidence in verapamil-infused isolated rat livers.
      R Mehvar and J Reynolds
      Drug Metabolism and Disposition June 1995, 23 (6) 637-641;

  4. Roberts, S M

    1. Increased blood and brain cocaine concentrations with ethanol cotreatment in mice.
      S M Roberts, D L Phillips and I R Tebbett
      Drug Metabolism and Disposition June 1995, 23 (6) 664-666;

  5. Rodrigues, A D

    1. Regulation of the Ah gene battery via Ah receptor-dependent and independent processes in cultured adult rat hepatocytes.
      G H Xiao, J A Pinaire, A D Rodrigues and R A Prough
      Drug Metabolism and Disposition June 1995, 23 (6) 642-650;

  6. Rodriguez, L C

    1. Metabolism of cyclosporin G in the mouse, rat, and dog.
      J B Mangold, L C Rodriguez and Y K Wang
      Drug Metabolism and Disposition June 1995, 23 (6) 615-621;

S

  1. Savrin, J E

    1. Urine chromium screening.
      J A Fagliano, M Gochfeld, J E Savrin and A H Stern
      Drug Metabolism and Disposition June 1995, 23 (6) 607-609;

  2. Stern, A H

    1. Urine chromium screening.
      J A Fagliano, M Gochfeld, J E Savrin and A H Stern
      Drug Metabolism and Disposition June 1995, 23 (6) 607-609;

  3. Suzuki, T

    1. Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers.
      L Y Lin, Y Kumagai, A Hiratsuka, S Narimatsu, T Suzuki, Y Funae, E W Distefano and A K Cho
      Drug Metabolism and Disposition June 1995, 23 (6) 610-614;

T

  1. Tebbett, I R

    1. Increased blood and brain cocaine concentrations with ethanol cotreatment in mice.
      S M Roberts, D L Phillips and I R Tebbett
      Drug Metabolism and Disposition June 1995, 23 (6) 664-666;

  2. Trager, W F

    1. Inhibition of (S)-warfarin metabolism by sulfinpyrazone and its metabolites.
      M He, K L Kunze and W F Trager
      Drug Metabolism and Disposition June 1995, 23 (6) 659-663;

V

  1. Vermeulen, N P

    1. Computer prediction and experimental validation of cytochrome P4502D6-dependent oxidation of GBR 12909.
      M J de Groot, G J Bijloo, K T Hansen and N P Vermeulen
      Drug Metabolism and Disposition June 1995, 23 (6) 667-669;

W

  1. Wang, Y K

    1. Metabolism of cyclosporin G in the mouse, rat, and dog.
      J B Mangold, L C Rodriguez and Y K Wang
      Drug Metabolism and Disposition June 1995, 23 (6) 615-621;

  2. White, C A

    1. Lymphatic distribution of 3'-azido-3'-deoxythymidine and 3'-azido-2',3'-dideoxyuridine in mice.
      K K Manouilov, C A White, F D Boudinot, I I Fedorov and C K Chu
      Drug Metabolism and Disposition June 1995, 23 (6) 655-658;

X

  1. Xiao, G H

    1. Regulation of the Ah gene battery via Ah receptor-dependent and independent processes in cultured adult rat hepatocytes.
      G H Xiao, J A Pinaire, A D Rodrigues and R A Prough
      Drug Metabolism and Disposition June 1995, 23 (6) 642-650;
Back to top

In this issue

Advertisement